Importantly, our data demonstrate that protection from T1D in VSL#3-treated NOD mice is associated with a significant decrease in IL-1β expression, thus suggesting a causative link between inflammasome activation, inflammation in the intestine, and autoimmune pathogenesis of T1D. The gene discussed is IL1B; the disease is type 1 diabetes mellitus.